564 related articles for article (PubMed ID: 33724423)
1. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City.
Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B;
Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423
[TBL] [Abstract][Full Text] [Related]
2. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
[TBL] [Abstract][Full Text] [Related]
3. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
Chong WH; Neu KP
J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
[TBL] [Abstract][Full Text] [Related]
4. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
5. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
[TBL] [Abstract][Full Text] [Related]
6. Aspergillosis in Critically Ill Patients with and Without COVID-19 in a Tertiary Hospital in Southern Brazil.
Trápaga MR; Poester VR; Basso RP; Blan BDS; Munhoz LS; Pasqualotto AC; Werner TDF; Figurelli ML; Stevens DA; von Groll A; Xavier MO
Mycopathologia; 2024 Jun; 189(3):48. PubMed ID: 38847987
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study.
Tamayo-Velasco Á; López-Herrero R; Gómez-García LM; Sánchez-de Prada L; Aguilar-Monserrate G; Martín-Fernández M; Bardají-Carrillo M; Álvaro-Meca A; Tamayo E; Resino S; Miramontes-González JP; Peñarrubia-Ponce MJ
J Infect Public Health; 2024 Jun; 17(6):939-946. PubMed ID: 38613930
[TBL] [Abstract][Full Text] [Related]
8. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
[TBL] [Abstract][Full Text] [Related]
9. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
[TBL] [Abstract][Full Text] [Related]
10. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.
Chong WH; Saha BK; Neu KP
Infection; 2022 Feb; 50(1):43-56. PubMed ID: 34570355
[TBL] [Abstract][Full Text] [Related]
11. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
[TBL] [Abstract][Full Text] [Related]
13. Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.
Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV
Rev Esp Anestesiol Reanim (Engl Ed); 2022 Jan; 69(1):48-53. PubMed ID: 35033481
[TBL] [Abstract][Full Text] [Related]
14. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
Verweij PE; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Buil JB; Calandra T; Chiller T; Clancy CJ; Cornely OA; Depuydt P; Koehler P; Lagrou K; de Lange D; Lass-Flörl C; Lewis RE; Lortholary O; Liu PL; Maertens J; Nguyen MH; Patterson TF; Rijnders BJA; Rodriguez A; Rogers TR; Schouten JA; Wauters J; van de Veerdonk FL; Martin-Loeches I
Intensive Care Med; 2021 Aug; 47(8):819-834. PubMed ID: 34160631
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
[TBL] [Abstract][Full Text] [Related]
16. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.
Jiang Z; Chen S; Zhu Q; Xiao Y; Qu J
J Infect Public Health; 2022 Feb; 15(2):222-227. PubMed ID: 35032951
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19).
Dupont D; Menotti J; Turc J; Miossec C; Wallet F; Richard JC; Argaud L; Paulus S; Wallon M; Ader F; Persat F
Med Mycol; 2021 Jan; 59(1):110-114. PubMed ID: 32914189
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.
Meijer EFJ; Dofferhoff ASM; Hoiting O; Meis JF
Mycoses; 2021 Apr; 64(4):457-464. PubMed ID: 33569857
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.
Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M
J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
